- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07936019
Evaluating PEDIDOSIS App in Pediatric CPR Simulations (Pedidosis app)
Effect of a Mobile App on Medication Errors During Simulated Pediatric Cardiopulmonary Resuscitation: PEDIDOSIS App vs. Conventional Methods. A Multicenter Simulation-based Randomized Controlled Trial
Despite its low incidence, pediatric cardiopulmonary arrest remains associated with high mortality and morbidity. The adequate preparation and administration of drugs can impact favourably on the outcomes of cardiopulmonary resuscitation.
Nursing staff rely on cognitive aids such as paper support, calculators, or spreadsheets to ensure correct drug administration.
Numerous strategies have been proposed to prevent medication errors, including the emergence of mHealth.
This study evaluates the efficacy and usefulness of the PEDIDOSIS smartphone application (app) for nursing staff in a simulated pediatric emergency setting. A multicentre high-fidelity simulation-based randomized controlled trial was conducted in a pediatric emergency setting with nursing professionals from different hospitals in Spain. Randomisation groups: PEDIDOSIS app (La Paz Hospital, Spain) vs. conventional methods (such as printed or electronic medication tables, smartphones, calculators or no cognitive aid). To avoid bias due to differences in pediatric emergency experience, each group was randomly assigned the same number of participants with experience (> 5 years) and without experience (≤ 5 years). Epinephrine, bicarbonate, midazolam, and norepinephrine on two ocassions were administered in a simulation scenario. Number and magnitude of medication errors, time taken to drug administration were evaluated as measured with video recording; stress, satisfaction, and usability as measured using standardized survey tools were evaluated.
One-hundred and five nurses participated. The incidence of wrong dose administration by any deviation from the correct dose was 51.5% for the control group vs. 26.4% for the PEDIDOSIS app group (p < 0.001). The OR for a wrong dose administration > 10% deviation with PEDIDOSIS app vs. conventional methods was 0.24 [0.14-0.4]), with a risk difference of 20.7%. The proportion of participants committing several medication errors (ME) was substantially lower with the app (15.1%) than with conventional methods (57.7%). Overall satisfaction regarding drug preparation was higher and stress lower in the app group. The System Usability Scale (SUS) score obtained for PEDIDOSIS app was 78.9 out of 100.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Madrid, Spagna
- Hospital Universitario La Paz
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Bambino
- Adulto
- Adulto più anziano
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- nurses or pediatric nursing residents working in a pediatric emergency department
Exclusion Criteria:
- unwillingness to participate or failure to complete the intervention
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: App group
Nurses that use app PEDIDOSIS during simulation |
Clinical decision support software (pedidosis) used for calculating pediatric drug dosages during simulated pediatric emergencies. |
|
Nessun intervento: Conventional methods group
Nurses that use conventional methods (such as printed or electronic medication tables, smartphones, calculators or no cognitive aid) during simulation |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Incidence of wrong dose administrations
Lasso di tempo: Perioperative/Periprocedural
|
Any deviation from the correct dose |
Perioperative/Periprocedural
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Time to adminsitration
Lasso di tempo: Perioperative/Periprocedural
|
the elapsed time in seconds between the oral prescription by the physician and the time participants delivered the drug |
Perioperative/Periprocedural
|
|
Incorrect preparation
Lasso di tempo: Perioperative/Periprocedural
|
when there was a deviation from the maximum recommended concentration for the dilution of each drug |
Perioperative/Periprocedural
|
Collaboratori e investigatori
Sponsor
Pubblicazioni e link utili
Pubblicazioni generali
- Siebert JN, Ehrler F, Combescure C, Lovis C, Haddad K, Hugon F, Luterbacher F, Lacroix L, Gervaix A, Manzano S; PedAMINES Trial Group. A mobile device application to reduce medication errors and time to drug delivery during simulated paediatric cardiopulmonary resuscitation: a multicentre, randomised, controlled, crossover trial. Lancet Child Adolesc Health. 2019 May;3(5):303-311. doi: 10.1016/S2352-4642(19)30003-3. Epub 2019 Feb 21.
- Corazza F, Arpone M, Tardini G, Stritoni V, Mormando G, Graziano A, Navalesi P, Fiorese E, Portalone S, De Luca M, Binotti M, Tortorolo L, Salvadei S, Nucci A, Monzani A, Genoni G, Bazo M, Cheng A, Frigo AC, Da Dalt L, Bressan S. Effectiveness of a Novel Tablet Application in Reducing Guideline Deviations During Pediatric Cardiac Arrest: A Randomized Clinical Trial. JAMA Netw Open. 2023 Aug 1;6(8):e2327272. doi: 10.1001/jamanetworkopen.2023.27272.
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- PI-6112
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .